I'm not here on behalf of the multinational pharmaceutical industry, but Canada is a small market.
We want to have access to the latest technologies. If our patent regime delivers the right qualities of being predictable, stable, flexible, and consistent, then companies will be able to commercialize their technologies here and have a market here. They'll want to file their patents here so that they have access to the market.
There are many markets in the world that will always have tremendous attractiveness because they're just larger markets.